Eating a Mediterranean-style diet can help people manage IBD symptoms, and a new cookbook from Crohn's & Colitis Ireland ...

Phase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ulcerative colitis (“UC”) reaches 1,003 of 1,224 participants, representing 82% of target enrollment. Enrollment completion ...

CU-06 is under clinical development by Curacle and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase I drugs for Ulcerative Colitis have an 82% phase transition success rate ...

While many treatments are approved by the Food and Drug Administration (FDA) for both forms of IBD, others are only approved for either Crohn's disease or ulcerative colitis. What's more, certain ...

Cleveland Clinic digestive health experts come to the rescue with "maneuvers and techniques," as they say, to get things ...

although the majority can benefit from treatment. A number of preliminary studies suggest that certain natural remedies for depression may work well for some people, but more studies are needed to ...

The best natural shampoos and conditioners eschew artificial ingredients for naturally derived alternatives that are generally less harsh and, in some cases, even work to actively restore balance ...

Ulcerative colitis causes ulcers in your large intestine that can lead to gastrointestinal problems. Some people with ulcerative colitis develop symptoms in other body parts, such as their joints ...

For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months compared with tofacitinib, according to a study published in the December ...

Natural remedies for IBS include dietary changes like increasing fiber intake, drinking peppermint tea, and consuming probiotics to balance gut bacteria. Other helpful options include yoga ...

Search Engine Land » PPC » Google files its proposed remedies in DOJ’s monopoly case Chat with SearchBot Please note that your conversations will be recorded. Google was required to file its ...

A pri­vate start­up from Salt Lake City aim­ing to de­vel­op oral an­ti­bod­ies says it has suc­ceed­ed in an ear­ly tri­al, a po­ten­tial­ly sig­nif­i­cant sci­en­tif­ic ad ...